OBJECTIVES: In a hereditary pancreatitis family from Denmark, we identified a novel intragenic duplication of 9 nucleotides in exon-2 of the human cationic trypsinogen (PRSS1) gene (c.63_71dup) which at the amino-acid level resulted in the insertion of 3 amino acids within the activation peptide of cationic trypsinogen (p.K23_I24insIDK). The aim of the present study was to characterize the effect of this unique genetic alteration on the function of human cationic trypsinogen. METHODS: Wild-type and mutant cationic trypsinogens were produced recombinantly and purified to homogeneity. Trypsinogen activation was followed by enzymatic assays and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Trypsinogen secretion was measured from transfected HEK 293T cells. RESULTS: Recombinant cationic trypsinogen carrying the p.K23_I24insIDK mutation exhibited greater than 10-fold increased autoactivation. Activation by human cathepsin B also was accelerated by 10-fold. Secretion of the p.K23_I24insIDK mutant from transfected cells was diminished, consistent with intracellular autoactivation. CONCLUSIONS: This is the first report of an intragenic duplication within the PRSS1 gene causing hereditary pancreatitis. The accelerated activation of p.K23_I24insIDK by cathepsin B is a unique biochemical property not found in any other pancreatitis-associated trypsinogen mutant. In contrast, the robust autoactivation of the novel mutant confirms the notion that increased autoactivation is a disease-relevant mechanism in hereditary pancreatitis.
OBJECTIVES: In a hereditary pancreatitis family from Denmark, we identified a novel intragenic duplication of 9 nucleotides in exon-2 of the humancationic trypsinogen (PRSS1) gene (c.63_71dup) which at the amino-acid level resulted in the insertion of 3 amino acids within the activation peptide of cationic trypsinogen (p.K23_I24insIDK). The aim of the present study was to characterize the effect of this unique genetic alteration on the function of humancationic trypsinogen. METHODS: Wild-type and mutant cationic trypsinogens were produced recombinantly and purified to homogeneity. Trypsinogen activation was followed by enzymatic assays and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Trypsinogen secretion was measured from transfected HEK 293T cells. RESULTS: Recombinant cationic trypsinogen carrying the p.K23_I24insIDK mutation exhibited greater than 10-fold increased autoactivation. Activation by humancathepsin B also was accelerated by 10-fold. Secretion of the p.K23_I24insIDK mutant from transfected cells was diminished, consistent with intracellular autoactivation. CONCLUSIONS: This is the first report of an intragenic duplication within the PRSS1 gene causing hereditary pancreatitis. The accelerated activation of p.K23_I24insIDK by cathepsin B is a unique biochemical property not found in any other pancreatitis-associated trypsinogen mutant. In contrast, the robust autoactivation of the novel mutant confirms the notion that increased autoactivation is a disease-relevant mechanism in hereditary pancreatitis.
Authors: Peter Simon; F Ulrich Weiss; Klaus Peter Zimmer; Steven Rand; Bernd Brinkmann; Wolfram Domschke; Markus M Lerch Journal: JAMA Date: 2002-11-06 Impact factor: 56.272
Authors: W Halangk; M M Lerch; B Brandt-Nedelev; W Roth; M Ruthenbuerger; T Reinheckel; W Domschke; H Lippert; C Peters; J Deussing Journal: J Clin Invest Date: 2000-09 Impact factor: 14.808
Authors: N Howes; W Greenhalf; S Rutherford; M O'Donnell; R Mountford; I Ellis; D Whitcomb; C Imrie; B Drumm; J P Neoptolemos Journal: Gut Date: 2001-02 Impact factor: 23.059
Authors: Zoltán Kukor; Julia Mayerle; Burkhard Krüger; Miklós Tóth; Paul M Steed; Walter Halangk; Markus M Lerch; Miklós Sahin-Tóth Journal: J Biol Chem Date: 2002-04-03 Impact factor: 5.157
Authors: Julia Mayerle; Matthias Sendler; Eszter Hegyi; Georg Beyer; Markus M Lerch; Miklós Sahin-Tóth Journal: Gastroenterology Date: 2019-01-18 Impact factor: 22.682